Literature DB >> 10634204

Abacavir in combination with the inosine monophosphate dehydrogenase (IMPDH)-inhibitor mycophenolic acid is active against multidrug-resistant HIV-1.

A Heredia, D Margolis, D Oldach, R Hazen, N Le, R Redfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10634204     DOI： 10.1097/00126334-199912010-00013

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  9 in total

Review 1.  Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity.

Authors:  M L Ritter; L Pirofski
Journal:  Transpl Infect Dis       Date:  2009-05-26       Impact factor: 2.228

2.  Liver transplantation in HCV/HIV positive patients.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  World J Gastrointest Surg       Date:  2011-02-27

Review 3.  Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient.

Authors:  Peter Chin-Hong; George Beatty; Peter Stock
Journal:  Infect Dis Clin North Am       Date:  2013-03-29       Impact factor: 5.982

Review 4.  A review of the pharmacokinetics of abacavir.

Authors:  Geoffrey J Yuen; Steve Weller; Gary E Pakes
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 5.  Solid organ transplants in HIV-infected patients.

Authors:  Jack Harbell; Norah A Terrault; Peter Stock
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

6.  Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.

Authors:  Laura L Hermann; Kevin M Coombs
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 7.  Kidney disease in children and adolescents with perinatal HIV-1 infection.

Authors:  Rajendra Bhimma; Murli Udharam Purswani; Udai Kala
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

8.  A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil.

Authors:  Rupinderjeet Kaur; Roger Bedimo; Mary Beth Kvanli; Diana Turner; Leslie Shaw; David Margolis
Journal:  AIDS Res Ther       Date:  2006-05-26       Impact factor: 2.250

Review 9.  Investigational drugs with dual activity against HBV and HIV (Review).

Authors:  Shiyu Sun; Qing Yang; Yunjian Sheng; Yi Fu; Changfeng Sun; Cunliang Deng
Journal:  Exp Ther Med       Date:  2020-11-11       Impact factor: 2.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.